Jakob Dupont - EVP, Head of R&D at Atara Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Head of R&D
Issuer Symbol
ATRA on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jakob Dupont since 06 Mar 2025

Holdings reported by Jakob Dupont for Atara Biotherapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 290,794 $113,119 $0.3890 02 Mar 2023 Direct
Employee Stock Option (Right to Buy) 317,987 01 Mar 2023 Direct Common Stock

Transactions reported by Jakob Dupont for Atara Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.